The German magazine Der Spiegel spoke with Lotte Bjerre Knudsen, the Danish chemist whose research laid the foundation for the creation of semaglutide, the diabetes and weight loss medication sold under the brand names Ozempic and Wegovy, which has generated billions of dollars in revenue for Novo Nordisk (so much revenue that the company is now worth more than the entire Danish economy). Knudsen has no share in either the stock of Novo Nordisk or the intellectual property behind the drugs, and has never even asked for a raise in her 34 years working at the pharmaceutical giant. “I don’t care that much about money, I’m a socialist!” she says (via The Browser)